Skip to content
Lower risk Medical device recall · FDA · Published May 14, 2021

DeRoyal Angio Cath Removal Tray Recall: 0.5% Bupivacaine Mislabeling

DeRoyal recalls specific lot of Angio Cath Removal Tray (REF 89-9936.02) due to mislabeled 0.5% Bupivacaine instead of 1% Lidocaine. Affected units contain lot numbers 54368716 expiring 6/01/2022.

🇺🇸 FDA recall #Z-1834-2021Medical deviceDeRoyal ›
Take action

Contact the company

Recalling firmDeRoyal Industries Inc200 Debusk Ln · Powell, TN 37849-4703
✎ GovInfoNow plain-language explainer

DeRoyal is recalling a specific lot of Angio Cath Removal Tray (REF 89-9936.02) because it was mislabeled as containing 0.5% Bupivacaine instead of 1% Lidocaine. This could lead to incorrect medication use during surgical procedures. Read more at govinfonow.com/recall/62539-deroyal-angio-cath-removal-tray-recall-0-5-bupivacaine-mislabeling.

Source Summary by GovInfoNow · govinfonow.com/recall/62539-deroyal-angio-cath-removal-tray-recall-0-5-bupivacaine-mislabeling · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1834-2021

Cite this page

“DeRoyal Angio Cath Removal Tray Recall: 0.5% Bupivacaine Mislabeling.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62539-deroyal-angio-cath-removal-tray-recall-0-5-bupivacaine-mislabeling. Based on FDA recall #Z-1834-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1834-2021%22&limit=1).

The FDA announced on May 14, 2021, that DeRoyal Industries Inc is recalling the DeRoyal Angio Cath Removal Tray due to mislabeling of its lidocaine component. The product contains 0.5% Bupivacaine instead of the labeled Hospira Pfizer 1% Lidocaine.

How to tell if you have it

  • Brand: DeRoyal
  • Product: DeRoyal Angio Cath Removal Tray, REF 89-9936.02
  • Lot Numbers: 54368716, exp. 6/01/2022
  • Quantity: 60 trays
  • Distribution: US Nationwide to MS, VA, LA, and NY

The hazard

DeRoyal manufactured certain lots of surgical procedure pack products using Hospira Pfizer 1% Lidocaine which was subsequently recalled due to mislabeling. The product is 0.5% Bupivacaine.

Context

GovInfoNow's records show DeRoyal Industries Inc has 29 other recalls on record since June 7, 2017. Recent DeRoyal recalls include a myocardial probe recall on Aug. 20, 2026, and a Covaderm Plus dressing recall on May 18, 2026. Other recent recalls of similar products include Bard Groshong NXT Catheter Recall (May 21, 2026), Bard Provena Midline Catheters Recall (May 21, 2026), and Bard PowerMidline Catheter Recall (May 21, 2026).

How to tell if you have this one

Check for the product name 'DeRoyal Angio Cath Removal Tray' with reference number 89-9936.02. The affected lot number is 54368716, expiring June 1, 2022.

  • Brand
    DeRoyal
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Terminated
  • Distribution
    US Nationwide distribution to the states of MS, VA, LA, and NY.
Recall numberProduct, codes & lotsQuantity
Z-1832-2021DeRoyal Pacemaker Tray Pgybk, REF 89-6360.06; Lot Number 54239375, exp. 02/01/202212 trays
Z-1833-2021DeRoyal Heart Cath Procedure Pack, REF 89-6556.08; Lot Numbers: 54310362, exp. 01/01/2022; 54366825, exp. 01/01/202266 packs
Z-1834-2021DeRoyal Angio Cath Removal Tray, REF 89-9936.02; Lot Numbers: 54368716, exp. 6/01/202260 trays
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the tray. The affected lot is 54368716, expiring June 1, 2022.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 4 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution to the states of MS, VA, LA, and NY.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Louisiana, Mississippi, New York, Virginia.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: May 14, 202112. FDA classified it Class I: Jun 10, 202123. Published in FDA’s Enforcement Report: Jun 16, 202134. FDA terminated the recall: Apr 21, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1834-2021 (May 14, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1834-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA